Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Inhibrx Biosciences(INBX) the EBIT is -32.15 M (-17.38%), Beat estimate;the EPS is -2.34 (-26.49%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B100.00%
----
EBITExceed expectations
-0.03B17.38%
-0.03B27.60%
+0.00B10.22%
EPSExceed expectations
-2.3426.49%
-2.3929.19%
+0.05002.70%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf